Patient undergoing laparoscopic radical prostatectomy in steep trendelenburg position are at risk to develop complication from brain edema.
Ultrasound assessment of optical nerve sheath diameter is a simply, non-invasive method to estimate the increase of intracranial pressure. It is unknown how optical nerve sheath diameter changes after prolonged head down position.
Condition or disease | Intervention/treatment |
---|---|
Intracranial Hypertension Brain Edema Pneumoperitoneum Surgery, Laparoscopic | Diagnostic Test: Optical nerve sheath diameter ultrasound measurement |
Study Type : | Observational |
Actual Enrollment : | 20 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Optical Nerve Sheath Diameter Changes During Steep Trendelenburg Position for Laparoscopic Prostatectomy |
Actual Study Start Date : | May 13, 2019 |
Actual Primary Completion Date : | June 30, 2019 |
Actual Study Completion Date : | July 30, 2019 |
Group/Cohort | Intervention/treatment |
---|---|
Steep Trendelenburg
Patients undergoing elective laparoscopic prostatectomy in steep Trendelenburg position (25 degrees head down position)
|
Diagnostic Test: Optical nerve sheath diameter ultrasound measurement
In cases: ultrasound measurement of the diameter of the optical nerve sheath at (T1) baseline before the induction of general anesthesia (5 min after the beginning of mechanical ventilation in supine position); (T2) after 10 min from 25 degrees head down positioning and with pneumoperitoneum insufflation; (T3) after 60 min from T2, in head down position; (T4) after 10 min from tracheal tube removal, in supine position. In healthy controls: ultrasound measurement of the diameter of the optical nerve sheath at (T1) baseline in supine position; (T2) after 10 min from 25 degrees head down positioning; (T3) after 60 min from T2, in a head down position; (T4) after 10 min from positioning supine |
Healthy controls
Healthy awake volunteers undergoing steep Trendelenburg position (25 degrees head down position)
|
Diagnostic Test: Optical nerve sheath diameter ultrasound measurement
In cases: ultrasound measurement of the diameter of the optical nerve sheath at (T1) baseline before the induction of general anesthesia (5 min after the beginning of mechanical ventilation in supine position); (T2) after 10 min from 25 degrees head down positioning and with pneumoperitoneum insufflation; (T3) after 60 min from T2, in head down position; (T4) after 10 min from tracheal tube removal, in supine position. In healthy controls: ultrasound measurement of the diameter of the optical nerve sheath at (T1) baseline in supine position; (T2) after 10 min from 25 degrees head down positioning; (T3) after 60 min from T2, in a head down position; (T4) after 10 min from positioning supine |
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Italy | |
ASST Fatebenefratelli Sacco, Luigi Sacco Hospital | |
Milan, Italy, 20157 |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | May 19, 2019 | ||||
First Posted Date | May 21, 2019 | ||||
Last Update Posted Date | January 5, 2021 | ||||
Actual Study Start Date | May 13, 2019 | ||||
Actual Primary Completion Date | June 30, 2019 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Optical nerve sheath diameter changes during steep Trendelenburg position [ Time Frame: 2 months ] changes of optical nerve sheath diameter in millimeters measured by ultrasound in patients undergoing laparoscopic radical prostatectomy and in healthy volunteers
|
||||
Original Primary Outcome Measures |
Optical nerve sheath diameter changes during steep Trendelenburg position [ Time Frame: 2 months ] To measure the optical nerve sheath diameter variations in patients undergoing laparoscopic radical prostatectomy and in healthy volunteers
|
||||
Change History | |||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Optical Nerve Sheath Changes During Head Down Laparoscopy | ||||
Official Title | Optical Nerve Sheath Diameter Changes During Steep Trendelenburg Position for Laparoscopic Prostatectomy | ||||
Brief Summary |
Patient undergoing laparoscopic radical prostatectomy in steep trendelenburg position are at risk to develop complication from brain edema. Ultrasound assessment of optical nerve sheath diameter is a simply, non-invasive method to estimate the increase of intracranial pressure. It is unknown how optical nerve sheath diameter changes after prolonged head down position. |
||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Probability Sample | ||||
Study Population | Patients undergoing elective laparoscopic radical prostatectomy | ||||
Condition |
|
||||
Intervention | Diagnostic Test: Optical nerve sheath diameter ultrasound measurement
In cases: ultrasound measurement of the diameter of the optical nerve sheath at (T1) baseline before the induction of general anesthesia (5 min after the beginning of mechanical ventilation in supine position); (T2) after 10 min from 25 degrees head down positioning and with pneumoperitoneum insufflation; (T3) after 60 min from T2, in head down position; (T4) after 10 min from tracheal tube removal, in supine position. In healthy controls: ultrasound measurement of the diameter of the optical nerve sheath at (T1) baseline in supine position; (T2) after 10 min from 25 degrees head down positioning; (T3) after 60 min from T2, in a head down position; (T4) after 10 min from positioning supine |
||||
Study Groups/Cohorts |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Completed | ||||
Actual Enrollment |
20 | ||||
Original Estimated Enrollment | Same as current | ||||
Actual Study Completion Date | July 30, 2019 | ||||
Actual Primary Completion Date | June 30, 2019 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 18 Years to 70 Years (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | Italy | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03957837 | ||||
Other Study ID Numbers | RIA02/2019 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | Riccardo Colombo, ASST Fatebenefratelli Sacco | ||||
Study Sponsor | ASST Fatebenefratelli Sacco | ||||
Collaborators | Not Provided | ||||
Investigators | Not Provided | ||||
PRS Account | ASST Fatebenefratelli Sacco | ||||
Verification Date | January 2021 |